论文部分内容阅读
自1964年至1977年经首次不同方法系统治疗宫内膜癌303例。全组五年生存率为61.7％;其中Ⅰ期78.6％,Ⅱ期73.2％,Ⅲ辨33.3％,Ⅳ期15.4％。 治疗方法包括:手术治疗、放射治疗和联合治疗。五年生存率:手术治疗为73.8％,其中Ⅰ期89.3％,Ⅱ期80.5％,Ⅲ期47.2％,Ⅳ期12.5％。放射治疗为29.5％,其中Ⅰ期35.7％,Ⅱ期40.6％,Ⅲ期16.1％,Ⅳ期0,联合治疗为68.4％,其中Ⅱ期91.3％,Ⅲ期36.4％,Ⅳ期25％。 晚期的宫内膜癌采用盆腔内动脉灌注抗癌药物可取得较好的疗效。
From 1964 to 1977, the first time different methods of treatment of 303 cases of endometrial cancer. The five-year overall survival rate was 61.7%; of which 78.6% in stage Ⅰ, 73.2% in stage Ⅱ, 33.3% in stage Ⅲ and 15.4% in stage Ⅳ. Treatments include: Surgical treatment, radiotherapy and combination therapy. Five-year survival rate: Surgical treatment was 73.8%, of which 89.3% of Ⅰ, 80.5% of stage Ⅱ, stage 47.2%, stage Ⅳ 12.5%. Radiotherapy was 29.5%, of which 35.7% were in stage I, 40.6% in stage II, 16.1% in stage III, 0 in stage IV and 68.4% in combination therapy, of which 91.3% were in stage II, 36.4% in stage III and 25% in stage IV. Advanced endometrial cancer with intra-arterial infusion of anticancer drugs can achieve better results.